Urgent Need for Biospecimens
With the advent of sophisticated molecular techniques like next generation sequencing (NGS) and multi-dimensional flow cytometry, the biomedical research community is able to capture an exquisite level of detail of healthy and disease states. Understanding exactly how much variation is “normal” and which differences define disease requires analyzing samples from a large number of individuals.
Which is why Audubon needs your help.
By partnering with Audubon, you can help your patients make a difference for the future management of their disease. All it takes is a small portion of tissue or biofluids.
Help your patients help others and partner with Audubon. Get started by contacting us.
NCI's Patient Guide to Donation
Personalized Medicine - Opportunities, Challenges and the Future
Find Out How Precision Oncology Can Help You Beat Cancer
Partner With Us
If you’d like to become an Audubon partner or need more information about our ethics policy, collection procedures, or how Audubon maximizes the impact of every donation, please click on the link to contact us.
Why You Should Partner With Audubon
Advance Medical Discovery
Accelerate the discovery and development of new diagnostic and therapeutic options.
Improve patient wellbeing by giving them a way to help others with the same disease
Cover Operational Costs While Making a Difference
Convert medical waste into a revenue stream that also drives biomedical advances.
Bringing New Treatments to the Clinic
Here are just a few examples of life-saving therapies and diagnostics developed through the generous donation of biospecimens from patients like you
- New biomarkers discovery and validation
- Unraveling disease resistance mechanisms
- Successful drug and therapy combinations
- New target identification
Research We Support
We provide biospecimens for leading organizations, including the US National Cancer Institute (NCI) and US Center for Disease Control (CDC), top pharma and biotech companies, as well as small and mid-sized start-ups.
We strongly support the research of autoimmune disorders by providing specimens from Diabetes type 1 and 2, Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease and many other conditions to leading industry, academic and governmental organizations.
With the increased incidence of viral outbreaks we are witnessing today, including the Covid-19 pandemic, samples from patients affected by infectious diseases are precious and an indispensable tool for the protection of public health. We are committed to provide such specimens and to support vaccine and therapeutic development.
Neurological disorders affect human wellbeing and quality of life on a global scale. By providing specimens from donors affected by such pathologies, we support the work of public and private institutions with the goal of identifying better biomarkers, revealing diseases’ molecular mechanisms and finding better treatments.